Prime Medicine 2024财年GAAP每股收益$(1.65),优于预期$(1.66),销售额$2.983M,超出预期$929.100K。以上内容来自Benzinga Earnings专栏,原文如下:Prime Medicine FY 2024 GAAP EPS $(1.65) Beats $(1.66) Estimate, Sales $2.983M Beats $929.100K Estimate
精彩评论